Empathy Through Pain Control: Lidocaine Gel vs. Placebo Prior to IUD Placement
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · May 7, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Empathy Through Pain Control," aims to understand how different types of numbing gels affect pain levels during the insertion of an intrauterine device (IUD) in women who have never given birth. The study will compare a lidocaine gel, which numbs the area, to a regular gel that doesn’t contain medication. Researchers are also interested in how patients feel about the empathy shown by their healthcare providers during this procedure.
To participate, women aged 18-50 who are English-speaking and seeking an IUD for contraception or heavy menstrual bleeding may be eligible. It’s important that participants have never given birth and do not have a history of certain medical issues, like chronic pain or substance use. If you join the study, you can expect to receive either the numbing gel or the non-medicated gel before the IUD placement, and your experience and pain levels will be monitored. Overall, this research may help improve pain management and the care experience for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Ability to provide informed consent
- • 2. Women presenting for IUD placement for contraception or heavy menstrual bleeding
- • 3. Ages 18-50
- • 4. English-speaking
- • 5. Participants must not have a past medical history of substance use disorders, pain disorders, use of prescription pain medications or are found to be pregnant
- • 6. Nulliparous (never given birth)
- Exclusion Criteria:
- • 1. History of ever giving birth
- • 2. Current use of prescription pain medication prior to procedure. Over-the-counter medications such as those containing ibuprofen, aspirin, acetaminophen, or naproxen are allowed.
- • 3. Diagnosed chronic pain condition
- • 4. Current pregnancy
- • 5. Known allergic reactions to components of the local anesthetic
- • 6. History of an IUD placement
- • 7. Current substance use or history of substance use
- • 8. Known contraindications to IUD, such as unexplained vaginal bleeding
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sheila K Mody, MD, MPH
Principal Investigator
UC San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported